Durect Corp (DRRX) Dividend History

Durect Corporation (DRRX) is a biopharmaceutical company focused on the development and commercialization of innovative drugs and delivery technologies. Its portfolio includes treatments for pain management, albumin therapies, and other specialty therapeutics, leveraging proprietary drug delivery platforms to improve patient outcomes.

10240 Bubb Road, Cupertino, CA, 95014
Phone: (408) 777-1417
Website: https://www.durect.com

Dividend History

Durect Corp currently does not pay dividends

Company News

DURECT Corporation to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide a Business Update

DURECT Corporation, a late-stage biopharmaceutical company, will report its fourth quarter and full year 2024 financial results and provide a business update on March 26, 2025. The company is pioneering the development of epigenetic therapies to transform the treatment of serious and life-threatening conditions, including acute organ injury.

Benzinga
Are Medical Stocks Lagging DURECT (DRRX) This Year?

Here is how Durect (DRRX) and Elevance Health (ELV) have performed compared to their sector so far this year.

Zacks Investment Research

Featured Companies: ELV
Rare Stock Picks In November 2023 - From 31 Discerning Analysts

Welcome to another installment of our monthly Rare Stock Picks article, where we highlight investment picks you may have missed. Explore more details here.

Seeking Alpha

Featured Companies: AKR ALB APP BRW BV BZH CCK DG EMR EXPE FRO IEFA LIN MRK MSFT SPHR SPRU TLT TTSH VLGEA WEAV XENE XMTR ZS

Page data last updated 07/22/2025 17:12:01 UTC